How could HIV infect the mouth and throat?

Published: 07 April 2009

At least one test-tube study1 has shown that cells in the lining of the mouth (known as normal human oral keratinocytes) can become infected when exposed to high concentrations of HIV, and can pass this infection on to lymphocytes. The tonsils also appear to be susceptible to infection,2 and infectious HIV has been found in high levels in the tissues of the pharynx and the tonsils.

However, while the vaginal and rectal tissues contain many cells vulnerable to HIV infection (possessing receptors which enable HIV to bind onto them), few such cells are present in the mucous membrane of the mouth and throat. The tissue of the mouth and oesophagus is also very thick compared with genital tissues, and fluids stay in contact with it for a very short time because swallowing clears the mouth regularly. The mouth is therefore generally regarded as an unlikely route of HIV transmission.

There is also strong evidence that an enzyme in saliva called secretory leukocyte protease inhibitor (SLPI) prevents HIV infection of lymphocytes, and therefore inhibits HIV infection in the mouth and throat. HIV antibodies have also been found in saliva, but it is not clear how much of a protective role they play.3 4 A 1989 study showed that even when greatly diluted, saliva was still capable of preventing HIV infection of white blood cells. It is still unclear how this happens and which specific substance in saliva inhibits infection.5

There is no evidence to either prove or disprove whether HIV is destroyed in the stomach. Researchers assume that, like other viruses, HIV will be inactivated by the digestive enzymes and acidity of the stomach. It is not possible to say whether semen that enters the stomach might enter the bloodstream through stomach ulcers or other inflamed tissue, but it seems very likely that HIV transmission through the stomach is much less of a possibility than transmission through the mouth and throat.

References

  1. Liu X et al. Human immunodefiency virus type 1 infection and replication in normal human oral keratinocytes. Journal of Virology, 77: 3470-3476, 2003
  2. Stahl-Hennig C et al. The tonsil as a portal of entry for simian immunodeficiency virus (SIV). Fifteenth Annual Symposium for non-human primate models for AIDS, Seattle, Washington, abstract 17, September, 1997
  3. Fultz PN Components of saliva inactivate human immunodeficiency virus. Lancet ii: 1215, 1986
  4. Hasselrot K et al. Oral HIV-exposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men. AIDS (online edition), 2009
  5. Fox PC et al. Saliva inhibits HIV infectivity. Journal of the American Dental Association 116: 635-637, 1988
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.